Why the study?
Does metabolic syndrome impact left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation?
Population
Patients with nonvalvular atrial fibrillation undergoing radiofrequency catheter ablation
Comparison
Presence of Metabolic Syndrome (MetS) vs Absence of Metabolic Syndrome
Design
Cohort
Follow-up
long-term
Authors
Loading...
AF ablation decisions unaffected by MetS; leaves open mechanistic role of increased LA low-voltage areas.
Does metabolic syndrome impact left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation?
Metabolic syndrome is associated with increased left atrial low voltage areas but does not appear to worsen long-term clinical outcomes after radiofrequency ablation for atrial fibrillation.
Dinov et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: